According to Yicai News, Evusheld, the world’s only drug for pre-exposure prevention of COVID-19 that has been authorized by many regions including the United States, the United Kingdom and the European Union, has arrived in Hainan. This is the first time the drug has entered the country.
At present, the drug has not been listed in my country, but according to the relevant policies of the “Nine Articles of the State”, Evusheld can be used in the Hainan Boao Lecheng International Medical Tourism Pilot Zone.It is not yet possible to use medical insurance for settlement, and the price of two injections at one time is 13,300 yuan.
Evusheld (Enshida) is a new crown drug developed by AstraZeneca in the United Kingdom. On June 8, AstraZeneca announced the early outpatient treatment of mild to moderate COVID-19 therapy Evusheld (tixagevimab and cilgavimab, formerly known as AZD7442) TACKLE Positive results from the Phase III trial were published in The Lancet Respiratory Medicine.
The trial results showed that a single dose of Evusheld reduced the risk of developing severe COVID-19 or death by 50% in non-hospitalized patients with mild to moderate COVID-19 compared with placebo.
In patients treated within 3 days of symptom onset, the drug reduced risk by 88 percent.
Compared with the active immunization of vaccines, which allows one’s own immune system to produce antibodies, Enshide is a direct injection of antibodies, which belongs to passive immunization, and the protection effect is expected to last for 6 months.
Hashtags: new crown virus new crown pneumonia new crown vaccine
.
[related_posts_by_tax taxonomies=”post_tag”]
The post The world’s only new crown preventive medicine enters the country for the first time: 13,300 yuan cannot use medical insurance at a time appeared first on Gamingsym.